The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus
Clinical Immunology · 2026-12 · 288 · 110779
DOI: 10.1016/j.clim.2026.110779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2026-12. Verfasst von David S Pisetsky und 14 weiteren Autor:innen. Beteiligte Einrichtung: Duke University School of Medicine, Department of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA. Electronic address: david.pis…. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Institute of Mental Health, National Institute on Minority Health and Health Disparities.
Abstract (Originalsprache)
The goal of these studies was to elucidate the relationship between levels of autoantibodies and complement (C3/C4) in the sera of patients with systemic lupus erythematosus (SLE) and thereby provide a framework for interpreting serological biomarkers in the context of current therapy. Anti-RNA-binding proteins (RBPs) were measured by enzyme-linked immunofluorescence assay (ELFA); ANA and autoantibodies to C1q and dsDNA were measured by ELISA; and levels of C3 and C4 were measured by immunoturbidimetry. In univariate analyses, anti-dsDNA, anti-C1q, anti-Sm, anti-U1RNP, and anti-RNP-70 were associated with low C3 and low C4 levels. In Lasso logistic regression and decision tree analysis, however, only anti-dsDNA and anti-C1q showed a relationship with complement in contrast to the other antinuclear antibodies. These studies support the important relationship between levels of anti-dsDNA and complement and further suggest that anti-C1q antibodies may also lead to complement activation, alone or in concert with other autoantibodies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke University School of Medicine, Department of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA. Electronic address: david.pisetsky@duke.edu.
- Duke University School of Medicine, Department of Biostatistics & Bioinformatics, Durham, NC, USA.
- Duke University School of Medicine, Department of Medicine, Durham, NC, USA.
- Immunovant, Inc., New York, NY, USA.
- Exagen, Inc., Vista, CA, USA.
Förderung
- National Institute of Mental Health
- National Institute on Minority Health and Health Disparities
Zitieren
APA
Pisetsky, D. S., Zhao, Y., Engelhard, M., Eudy, A., Tedeschi, P., O'Malley, T., Alexander, R. V., Clowse, M., Criscione-Schreiber, L., Doss, J., Maheswaranathan, M., Sadun, R., Sun, K., Harris, N., & Rogers, J. (2026). The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus. Clinical Immunology, 288, 110779. https://doi.org/10.1016/j.clim.2026.110779
Vancouver
Pisetsky DS, Zhao Y, Engelhard M, Eudy A, Tedeschi P, O'Malley T, et al. The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus. Clinical Immunology. 2026;288:110779. doi:10.1016/j.clim.2026.110779
BibTeX
@article{Pisetsky2026,
author = {Pisetsky, David S and Zhao, Yuankang and Engelhard, Matthew and Eudy, Amanda and Tedeschi, Philip and O'Malley, Tyler and Alexander, Roberta Vezza and Clowse, Megan and Criscione-Schreiber, Lisa and Doss, Jayanth and Maheswaranathan, Mithu and Sadun, Rebecca and Sun, Kai and Harris, Nathaniel and Rogers, Jennifer},
title = {The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus},
journal = {Clinical Immunology},
year = {2026},
volume = {288},
pages = {110779},
doi = {10.1016/j.clim.2026.110779}
}
EUVIMED